Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Reflux Nephropathy : Article by

Quick Find
Authors & Editors
Introduction
Radiograph
CT SCAN
MRI
Ultrasound
Nuclear Medicine
Angiography
Intervention
Multimedia
References




Patient Education
Click here for patient education.



Author: George Gross, MD, Chief of Pediatric Radiology, University of Maryland Medical Center; Professor, Department of Diagnostic Radiology, University of Maryland School of Medicine

George Gross is a member of the following medical societies: American College of Radiology, American Institute of Ultrasound in Medicine, American Medical Association, Association of University Radiologists, Radiological Society of North America, Society for Pediatric Radiology, and Society of Thoracic Radiology

Editors: Steven Perlmutter, MD, FACR, Clinical Associate Professor, Radiology Residency Program Director, Radiology Medical Director, Department of Radiology, University Hospital at Stony Brook; Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand; Joshua A Becker, MD, Professor, Department of Radiology, New York University School of Medicine; Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute; Eugene C Lin, MD, Consulting Staff, Department of Radiology, Virginia Mason Medical Center

Author and Editor Disclosure

Synonyms and related keywords: chronic pyelonephritis, renal scarring, renal parenchymal scarring, vesicoureteral reflux, VUR, urinary tract infections, UTIs, intrarenal reflux

Background

Hodson initially noted the association of vesicoureteral reflux (VUR) with renal parenchymal scarring.

Pathophysiology

Reflux nephropathy is based on persistent reflux of sterile or infected urine from the bladder to one or both kidneys via the ureters. Although sterile VUR may cause renal scarring, most studies indicate that the appearance of renal scarring or the extension of established renal scars requires infection (Escherichia coli is the common pathogen). The higher the grade of reflux, the greater the likelihood of development of new or progressive scarring in association with infection.

Intrarenal reflux, or the extension of VUR into the collecting tubules of the nephrons that allows urinary microorganisms access to the renal parenchyma, is believed to be particularly important in the development of renal scarring.

Radiologic evidence of renal scarring is noted in 30-60% of children with VUR, and VUR is present in almost all children with severe renal scarring. A direct correlation between the prevalence of scarring and the grade of VUR has been demonstrated.

Although VUR occurs at a similar rate in boys and girls, girls are at greater risk of developing reflux nephropathy because of increased incidence of urinary tract infection (UTI). In the absence of reflux and UTI, abnormalities of organ systems other than the genitourinary tract do not place a child at increased risk for developing reflux nephropathy.

Frequency

United States

The incidence of renal scarring in children resulting from VUR is unknown. The prevalence of VUR in asymptomatic children is less than 0.5%, but VUR is present in 29-50% of children with UTIs.

Mortality/Morbidity

The incidence of renal scarring in children caused by VUR is unknown. VUR is present in 29-50% of children with UTIs.

Race

VUR and reflux nephropathy occur less frequently in black children than in other groups of patients.

Sex

Reflux occurs at a similar rate in boys and girls; however, the much higher incidence of UTI in girls places them at greater risk for reflux nephropathy.

Age

In children, the occurrence of VUR decreases with increasing age. The vesicoureteral insertion matures just prior to puberty. The mature bladder wall intramural portion of the ureter attains its 1.5-cm length.

Anatomy

Most cases of VUR are considered primary because of incompetence of the ureterovesical junction (UVJ), and it is not secondary to either obstruction or infection. As the UVJ matures to assume its adult 1.5-cm oblique path through the bladder wall, VUR tends to decrease in severity and eventually disappears just before puberty. An exception is in patients with an anatomic abnormality such as a bladder diverticulum, into which the refluxing ureter enters. Incompetence of the UVJ resulting from a lack of maturation is the most common cause of VUR in children. Obstruction and infection rarely cause reflux. With maturation of the incompetent UVJ, reflux usually eventually resolves.

A small subgroup of children have a perpendicular ureteric insertion at the bladder wall, with a resultant golf-hole ureteric orifice. In these patients, surgical correction is necessary to eliminate VUR. A decision to perform a repair, either a ureteroneocystostomy or a collagen periurethral injection, is dependent on the appearance of the ureteric orifice. Nevertheless, all patient are covered with appropriate antibiotics to await the maturation of the intramural portion of the ureter or undergo surgery to stop the reflux.

Clinical Details

Children with reflux nephropathy may be asymptomatic, may present with nonspecific symptoms (eg, failure to thrive, fever, poor food intake), may be acutely ill in association with acute pyelonephritis, or may present with renal failure with advanced renal scarring associated with reflux nephropathy.

Vesicoureteral reflux is graded on a scale of 0-5. Grade 0 indicates no reflux; grade 1 indicates reflux into the ureter but not reaching the renal pelvis; grade 2 indicates reflux into the renal pelvis and calyces but without any dilatation; and grades 3, 4, and 5 indicate reflux to the renal pelvis and calyces with mild, moderate, and severe dilatation, respectively.

Preferred Examination

Renal ultrasonography (RUS) and voiding cystourethrography (VCUG) are the preferred radiologic methods. The 2 procedures provide complementary information. RUS helps in evaluating the upper urinary tract (kidneys and proximal portion of the collecting system) for anomalies, masses, calcification, hydronephrosis, and size and can identify renal scarring if moderate to severe in degree. VCUG helps in evaluating for VUR and the anatomy of the lower urinary tract (bladder and urethra).

Limitations of Techniques

Renal scarring is detected and identified better by using nuclear medicine renal scanning with a cortical imaging agent (eg, technetium-99m dimercaptosuccinic acid) than with ultrasonography.

Imaging with renal scanning may require sedation in younger children. Sedation is increasingly requested, although rarely necessary, for children undergoing VCUG.



Findings

Plain images offer no diagnostic information regarding VUR and reflux nephropathy, although they can be used to evaluate spinal anomalies and potential urinary tract calculi, which rarely occur in this population. VCUG is essential in evaluating lower urinary tract anatomy and in identifying or excluding VUR.

  • With voiding cystourethrography, contrast material is instilled in the urinary bladder via a transurethral catheter and demonstrates increased opacity in the ureters and pelvicaliceal systems when VUR is present. VUR grading (grades 0-5) is based on the distribution and degree of associated upper urinary tract dilatation demonstrated on VCUG.
  • Intravenous urography (IVU) can demonstrate changes reflecting reflux nephropathy and renal scarring, including the following:
    • Dilatation and deformity of one or more renal calyces
    • Loss of parenchymal thickness of a region of the kidney (especially upper and lower poles)
    • Focal contour indentation typically adjacent to a calyx, representing renal scarring

Degree of Confidence

With VCUG, the degree of confidence is high for detecting VUR and low for detecting chronic pyelonephritic scarring. With IVU, the degree of confidence is moderate for detecting chronic pyelonephritic scarring.

False Positives/Negatives

False findings occur infrequently; however, the soft tissue of the bowel wall can simulate contrast enhancement in a ureter, and overlying stool and intestinal gas can sufficiently obscure the kidney to prevent identification of lesser degrees of VUR.

Scarring from reflux nephropathy can usually be differentiated from scarring from other etiologies (such as parenchymal infarction) by the fact the calyx underlying the scar will be deformed in reflux nephropathy.



Findings

CT scanning is not indicated in the evaluation of reflux nephropathy because of radiation dose, the need for intravenously administered contrast material, and the potential need for patient sedation. However, CT scans can demonstrate renal scarring and hydronephrosis but not VUR.



Findings

MRI is not routinely indicated in the evaluation of reflux nephropathy because of cost of the procedure and the potential need for patient sedation. However, MRI can demonstrate renal scarring and hydronephrosis but not VUR.



Findings

Alteration of renal contour and reduced thickness to the renal parenchyma are the primary findings of reflux nephropathy. Ultrasonography is excellent for demonstrating upper urinary tract dilatation.

Echo-enhanced cystosonography performed by using ultrasonographic contrast media is a new diagnostic procedure with a major attribute in the exclusion of ionizing radiation.

Degree of Confidence

With ultrasonography, the degree of confidence is moderate in the detection of reflux nephropathy. Lesser degrees of renal scarring may not be evident with ultrasonography.

Echo-enhanced cystosonography, in limited experience, is reported to be as accurate as radiographic VCU in the identification of reflux.

False Positives/Negatives

Fetal lobation and other normal variants of renal development may be mistaken for renal scarring on sonograms.



Findings

Technetium-99m dimercaptosuccinic acid and technetium-99m glucoheptonate are scintigraphic agents with a high affinity for the renal cortex because they are concentrated by renal tubular cells. As a result, they produce a relatively high level of renal detail. Concern for acute pyelonephritis, the assessment of renal cortical scarring, and the identification of a malpositioned kidney are among the indications for cortical scintigraphy. The use of single-photon emission computed tomography increases sensitivity of the agents to changes of renal scarring and acute pyelonephritis.

Reduced accumulation of a cortical imaging isotope within the renal margins is an indication of renal scarring. Radionuclide cystogram provides an alternative to VCUG in identifying renal scarring. Cystograms have the primary disadvantage of poor anatomic resolution but the advantage of a lower radiation dose.

Degree of Confidence

Degree of confidence is high, with renal cortical imaging performed by using technetium-99m dimercaptosuccinic acid.

False Positives/Negatives

Patient motion, structural abnormalities of the kidneys, and unsatisfactory isotope administration may result in false-positive and false-negative findings.

Patient motion results in inaccurate imaging depiction of isotope distribution and greater probability of underestimating renal scarring (false-negative findings). Hydronephrosis, anomalies such as ectopic and/or fused kidneys, and renal masses or cysts may result in the overestimation of severity of renal scarring (false-positive findings).



Findings

Angiography does not play a role in the evaluation of reflux nephropathy.



Medical/Legal Pitfalls

  • The absence of demonstrated renal scarring in a child with VUR increases the likelihood of treating the child medically (with suppressive antibiotic therapy to prevent urinary tract infection), while the demonstration of moderate-to-severe scarring increases the probability of surgical management with ureteral reimplantation to prevent further reflux.
  • The failure to identify renal scarring and overestimating or underestimating the severity of scarring can lead to the inappropriate management of VUR.



Media file 1:  Sonogram in a child with recurrent urinary tract infections and vesicoureteral reflux. Focal contour indentation along the lower lateral margin of the left kidney (longitudinal view) reflects a focal pyelonephritic scar, which is an appearance distinct from the more global parenchymal scarring seen in Image 2.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image

Media file 2:  Longitudinal sonogram of the left kidney in an 18-year-old woman with a history of recurrent urinary tract infections demonstrates normal parenchymal thickness in the upper portion of the kidney and generalized marked parenchymal thinning in the lower portion. The latter reflects chronic pyelonephritic scarring secondary to urinary tract infection and vesicoureteral reflux that occurred in childhood.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image

Media file 3:  Anteroposterior digital view during voiding cystoureterography of the upper bladder to the kidneys demonstrates bilateral grade 5 vesicoureteral reflux, with severe dilatation of both ureters, the renal pelves, and the bilateral calyces (same patient as in Image 1).
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image

Media file 4:  A 15-minute postinjection anteroposterior view of the kidneys in a 9-year-old boy with a history of multiple urinary tract infections who presented with hypertension demonstrates bilateral diffuse calyceal clubbing (arrows) and deformity accompanied by thinning of the adjacent renal parenchyma (arrowheads). These findings reflect chronic pyelonephritis and demonstrate the characteristic appearance of reflux nephropathy on intravenous urography.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  X-RAY

Media file 5:  Renal scan by using the cortical imaging agent technetium-99m dimercaptosuccinic acid in a 2-year-old boy with a history of multiple urinary tract infections demonstrates diffuse bilateral renal scarring, which is indicated by the multifocal areas of absence of renal cortical isotope accumulation.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image



  • Assael BM, Guez S, Marra G, et al. Congenital reflux nephropathy: a follow-up of 108 cases diagnosed perinatally. Br J Urol. Aug 1998;82(2):252-257. [Medline].
  • Berrocal T, Gaya F, Arjonilla A. Vesicoureteral reflux: diagnosis and grading with echo-enhanced cystosonography versus voiding cystourethrography. Radiology. Nov 2001;221(2):359-65. [Medline].
  • Bjorgvinsson E, Majd M, Eggli KD. Diagnosis of acute pyelonephritis in children: comparison of sonography and 99mTc-DMSA scintigraphy. AJR Am J Roentgenol. Sep 1991;157(3):539-43. [Medline].
  • Casale P, Grady RW, Mitchell ME, Healey P. Recurrent urinary tract infection in the post-transplant reflux nephropathy patient: is reflux in the native ureter the culprit?. Pediatr Transplant. Jun 2005;9(3):324-7. [Medline].
  • Conway JJ, Cohn RA. Evolving role of nuclear medicine for the diagnosis and management of urinary tract infection. J Pediatr. Jan 1994;124(1):87-90. [Medline].
  • Darge K. Voiding urosonography with US contrast agents for the diagnosis of vesicoureteric reflux in children : II. Comparison with radiological examinations. Pediatr Radiol. Jul 18 2007;[Medline].
  • Elison BS, Taylor D, Van der Wall H, et al. Comparison of DMSA scintigraphy with intravenous urography for the detection of renal scarring and its correlation with vesicoureteric reflux. Br J Urol. Mar 1992;69(3):294-302. [Medline].
  • Farnsworth RH, Rossleigh MA, Leighton DM, et al. The detection of reflux nephropathy in infants by 99mtechnetium dimercaptosuccinic acid studies. J Urol. Mar 1991;145(3):542-6. [Medline].
  • Goonasekera CD, Dillon MJ. Hypertension in reflux nephropathy. BJU Int. Apr 1999;83 Suppl 3:1-12. [Medline].
  • Goonasekera CD, Gordon I, Dillon MJ. 15-year follow-up of reflux nephropathy by imaging. Clin Nephrol. Oct 1998;50(4):224-31. [Medline].
  • Kaneyama K, Yamataka A, Lane GJ, Someya T, Yamashiro Y, Miyano T. Requirement for screening for vesicoureteric reflux in children with multicystic dysplastic kidney: some considerations based on our experience and literature review. J Pediatr. Dec 2006;149(6):882-3; author reply 883-4. [Medline].
  • Kenda RB, Zupancic Z, Fettich JJ, Meglic A. A follow-up study of vesico-ureteric reflux and renal scars in asymptomatic siblings of children with reflux. Nucl Med Commun. Sep 1997;18(9):827-31. [Medline].
  • Konda R, Sakai K, Ota S, et al. Followup study of renal function in children with reflux nephropathy after resolution of vesicoureteral reflux. J Urol. Mar 1997;157(3):975-9. [Medline].
  • Lin CH, Yang LY, Wamg HH, Chang JW, Shen MC, Tang RB. Evaluation of imaging studies for vesicoureteral reflux in infants with first urinary tract infection. Acta Paediatr Taiwan. Mar-Apr 2007;48(2):68-72. [Medline].
  • Mastin ST, Drane WE, Iravani A. Tc-99m DMSA SPECT imaging in patients with acute symptoms or history of UTI. Comparison with ultrasonography. Clin Nucl Med. May 1995;20(5):407-12. [Medline].
  • McMahon LP, Katsoulis J, Troupis JM, Barit D, Delecheneau P. Use of magnetic resonance imaging to assess renal structure and function in reflux nephropathy. Nephrology (Carlton). Apr 2007;12(2):172-7. [Medline].
  • Merguerian PA, Jamal MA, Agarwal SK, et al. Utility of SPECT DMSA renal scanning in the evaluation of children with primary vesicoureteral reflux. Urology. May 1999;53(5):1024-8. [Medline].
  • Najmaldin A, Burge DM, Atwell JD. Reflux nephropathy secondary to intrauterine vesicoureteric reflux. J Pediatr Surg. Apr 1990;25(4):387-90. [Medline].
  • Polito C, La Manna A, Rambaldi PF, Valentini N, Marte A, Lama G. Long-term evolution of renal damage associated with unilateral vesicoureteral reflux. J Urol. Sep 2007;178(3):1043-7. [Medline].
  • Riccabona M, Ring E, Maurer U, et al. Scintigraphy and sonography in reflux nephropathy: a comparison. Nucl Med Commun. Apr 1993;14(4):339-42. [Medline].
  • Risdon RA. The small scarred kidney in childhood. Pediatr Nephrol. Aug 1993;7(4):361-4. [Medline].
  • Roberts JA. Mechanisms of renal damage in chronic pyelonephritis (reflux nephropathy). Curr Top Pathol. 1995;88:265-87. [Medline].
  • Rossleigh MA. Neonatal diagnosis with Tc-99m dimercaptosuccinic acid of intra-uterine reflux nephropathy in duplex kidneys. Clin Nucl Med. Nov 1996;21(11):897. [Medline].
  • Rushton HG, Majd M. Dimercaptosuccinic acid renal scintigraphy for the evaluation of pyelonephritis and scarring: a review of experimental and clinical studies. J Urol. Nov 1992;148(5 Pt 2):1726-32. [Medline].
  • Shimada K, Matsui T, Ogino T, et al. Renal growth and progression of reflux nephropathy in children with vesicoureteral reflux. J Urol. Nov 1988;140(5 Pt 2):1097-100. [Medline].
  • Smellie JM. The intravenous urogram in the detection and evaluation of renal damage following urinary tract infection. Pediatr Nephrol. Apr 1995;9(2):213-9; discussion 219-20. [Medline].
  • Smellie JM, Poulton A, Prescod NP. Retrospective study of children with renal scarring associated with reflux and urinary infection. BMJ. May 7 1994;308(6938):1193-6. [Medline].
  • Strife JL, Bisset GS 3rd, Kirks DR, et al. Nuclear cystography and renal sonography: findings in girls with urinary tract infection. AJR Am J Roentgenol. Jul 1989;153(1):115-9. [Medline].

Reflux Nephropathy excerpt

Article Last Updated: Aug 23, 2007